Orphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development.

Chandrabose S, Muniyandi V, Geddawy A, Thiyagarajan R, Murugesan A, Kandhavelu M

Open source

DOI
10.3389/fendo.2026.1916297
Published
2026
Container
Frontiers in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1916297,
  title = {Orphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development.},
  author = {Chandrabose S and Muniyandi V and Geddawy A and Thiyagarajan R and Murugesan A and Kandhavelu M},
  year = {2026},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2026.1916297},
  url = {https://doi.org/10.3389/fendo.2026.1916297}
}

RIS

TY  - JOUR
TI  - Orphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development.
AU  - Chandrabose S
AU  - Muniyandi V
AU  - Geddawy A
AU  - Thiyagarajan R
AU  - Murugesan A
AU  - Kandhavelu M
PY  - 2026
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1916297
UR  - https://doi.org/10.3389/fendo.2026.1916297
ER  - 

APA

S, C., V, M., A, G., R, T., A, M., & M, K. (2026). Orphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1916297

Source records